Literature DB >> 4701961

Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.

J J Schildkraut.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4701961     DOI: 10.1176/ajp.130.6.695

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  20 in total

1.  Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression.

Authors:  B Scatton; H Loo; T Dennis; C Benkelfat; C Gay; M F Poirier-Littre
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depression-syndrome.

Authors:  P Riederer; W Birkmayer; E Neumayer; L Ambrozi; W Linauer
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

Review 3.  Biochemical assessment of antidepressive drugs.

Authors:  K Ghose
Journal:  Br J Clin Pharmacol       Date:  1980-12       Impact factor: 4.335

4.  Strategies for the drug treatment of depression.

Authors:  A J Cooper; R V Magnus
Journal:  Can Med Assoc J       Date:  1984-02-15       Impact factor: 8.262

5.  Effect of antidepressant drugs on serotonergic and adrenergic receptors.

Authors:  S W Tang; P Seeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-04       Impact factor: 3.000

Review 6.  Amoxapine: a review of its pharmacology and efficacy in depressed states.

Authors:  S G Jue; G W Dawson; R N Brogden
Journal:  Drugs       Date:  1982-07       Impact factor: 9.546

7.  [Endocrinological prediction of the responsiveness of depressive patients to lofepramine (author's transl)].

Authors:  M Philipp; J Beyer; J Happ; U Krause
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979-07-04

8.  Clinical study of mianserin, imipramine and placebo in depression: blood level and MHPG correlations.

Authors:  G F Perry; B Fitzsimmons; L Shapiro; P Irwin
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

9.  Urinary 3-methoxy, 4-hydroxyphenylethylene glycol and therapeutic response to maprotiline and indalpine in major depression.

Authors:  H Loo; C Benkelfat; J M Vanelle; T Dennis; M F Poirier; J P Olie; B Scatton
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

10.  Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline.

Authors:  A F Schatzberg; A H Rosenbaum; P J Orsulak; W A Rohde; T Maruta; E R Kruger; J O Cole; J J Schildkraut
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.